Month: August 2024

[ad_1] Trials for psychedelic drug candidate for PTSD under scrutiny by FDA – report [ad_2] Source: Seekingalpha

[ad_1] JP Yim The head of the World Health Organization (WHO) has stated that a global response plan to fight the continuing mpox outbreak would require…

[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds…

[ad_1] travellinglight/iStock through Getty Images Shortly after a U.Ok. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s nationwide well…

[ad_1] U.Ozel.Images/E+ by way of Getty Images Although different corporations are poised to have GLP-1 receptor agonist medication for weight loss authorized, they don’t seem to…

[ad_1] Zhanna Hapanovich/iStock by way of Getty Images Evolent Health (EVH) could see $35 a share in a takeover from a personal fairness agency, based on…

[ad_1] Chinese medical device supplier WORK Medical prices U.S. IPO [ad_2] Source: Seekingalpha

[ad_1] Altamira Therapeutics extends distribution agreement with Pharma Nordic [ad_2] Source: Seekingalpha

[ad_1] Henrik5000/E+ through Getty Images Israel primarily based computational biology firm Evogene (NASDAQ:EVGN) mentioned on Friday it has entered into agreements with an institutional investor for…

[ad_1] spawns Shares of Inhibrx Biosciences (NASDAQ:INBX) added ~8% on Friday after its Chief Executive Officer, Mark Lappe, disclosed the purchase of 40K shares of the…